Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza

Clinical trial NCT06669351 · TERMINATED

Trial details

NCT number: NCT06669351
Sponsor: Nanjing Zenshine Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Viral Infection

Start date: 2024-10-31
Primary completion: 2025-07-15
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.